171 algorithm-development-"Multiple"-"Prof"-"UNIS"-"St" Postdoctoral positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
· Gender-friendly environment with multiple actions to attract, develop and retain women in science · 32 days’ paid annual leave, 11 public holidays, 13-month salary, statutory health insurance
-
opportunity to contribute to cutting-edge research at the intersection of artificial intelligence, machine learning, and healthcare. The successful candidate will develop and apply advanced machine learning
-
people to fulfil their personal and professional ambitions Gender-friendly environment with multiple actions to attract, develop and retain women in science 32 days’ paid annual leave, 11 public holidays
-
to a solid research program with clear project goals and strong support for career development. Key Research Techniques & Models: Mouse models: Knockout, conditional knockout, transgenic, and patient
-
metabolism. The candidate will be involved in the field of basic and translational diabetes and obesity research and drug discovery. The research in the lab involves the development and implementation
-
-640; Gastroenterology 2021 Jul 8:S0016-5085(21)03159-0; Nature Reviews Cancer 2023 Mar 27:1-20, Nature Cell Biology, 2024 May;26(5):840). Our program is well-funded by NCI, with multiple R01 grants and
-
assessments and modelling of food web dynamics and disease screening. This position provides a unique opportunity to contribute to our understanding of how multiple stressors including climate change
-
contributes to multiple peer-reviewed publications. Participates in the preparation and submission of grant applications. Develop and propose innovative research ideas, including new methods for data analysis
-
with multiple actions to attract, develop and retain women in science 32 days’ paid annual leave, 11 public holidays, 13-month salary, statutory health insurance Flexible working hours, home working
-
, like rituximab, can be effectively boosted by vaccination while others cannot (Gröning et al, Front Imm 2023). You will use recently developed technology in genomic and proteomic B cell / antibody